跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
臺北醫學大學生醫器材研究中心
臺北醫學大學
電話
+886-2-27361661#7701
電子郵件
[email protected]
網站
http://cbd.tmu.edu.tw/index.php
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(74)
專案
(444)
研究成果
(3475)
資料集
(79)
指紋
查看啟用 臺北醫學大學生醫器材研究中心 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Nanoparticle
79%
Chitosan
55%
Neoplasm
55%
Disease
52%
Cohort Study
50%
Mouse
47%
Randomized Controlled Trial
44%
Chronic Kidney Failure
44%
Reactive Oxygen Metabolite
40%
Inflammation
40%
Chronic Obstructive Lung Disease
37%
Gelatin
32%
Lung Cancer
30%
Hyaluronic Acid
30%
Fucoidan
29%
Hemodialysis
29%
Sleep Disordered Breathing
29%
Vaccination Policy
26%
Epidermal Growth Factor Receptor
26%
Endothelin 1
25%
Antioxidant
25%
Cytotoxicity
24%
Doxorubicin
23%
Combination Therapy
23%
Breast Cancer
21%
Infection
21%
Cell Viability
21%
Liposome
19%
Diabetes Mellitus
19%
Wound Healing
18%
Antiinfective Agent
18%
Chemotherapy
17%
Mitogen Activated Protein Kinase
17%
Cardiovascular Disease
17%
Symptom
17%
Adverse Event
17%
Growth Factor
17%
Angiotensin II
17%
Drug Delivery System
16%
Lipopolysaccharide
16%
Bipolar Disorder
16%
Injury
15%
Alginic Acid
15%
Tumor Necrosis Factor
15%
Tumor Growth
15%
Nitric Oxide
15%
Therapeutic Effect
15%
Rat Model
14%
Asthma
14%
Biocompatibility
14%
Cytokine
14%
Calcium Phosphate
14%
Nanocarrier
14%
Epigallocatechin Gallate
14%
Hydroxyapatite
12%
Prevalence
12%
Leporidae
12%
Survival Rate
12%
Acute Heart Infarction
12%
End Stage Renal Disease
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Polysaccharide
12%
Heart Infarction
12%
Wound
11%
Atrial Fibrillation
11%
Case-Control Study
11%
Parkinson's Disease
11%
Western Blot
11%
Biological Marker
11%
Mesoporous Silica Nanoparticle
11%
Implant
11%
Fibrinogen
11%
Fibrosis
11%
Non Small Cell Lung Cancer
11%
Drug Release
11%
Nanomaterial
11%
Lung Adenocarcinoma
10%
Liver Cell Carcinoma
10%
Mouse Model
10%
Infectious Agent
10%
Alkaline Phosphatase
10%
Urotensin II
10%
Sleep Disorder
10%
Polyglutamic Acid
10%
Clinical Trial
10%
Dry Eye
10%
Receptor
10%
Nuclear Factor
10%
Kidney Disease
10%
Thrombosis
10%
Placebo
10%
Resveratrol
10%
Cisplatin
9%
Non Insulin Dependent Diabetes Mellitus
9%
All Cause Mortality
9%
Cyclooxygenase 2
9%
Colon Cancer
9%
Side Effect
9%
Antihypertensive Agent
9%
Medicine and Dentistry
In Vitro
64%
Meta-Analysis
57%
Platelet
49%
Randomized Controlled Trial
47%
Implant
46%
Cohort Analysis
43%
Systematic Review
40%
Malignant Neoplasm
39%
Chronic Kidney Disease
35%
Apoplexy
35%
Platelet Lysate
34%
Medicine
34%
Isotopes of Calcium
30%
Chronic Obstructive Pulmonary Disease
29%
Restylane
29%
Disease
28%
Hazard Ratio
25%
Diabetes Mellitus
22%
Symptom
22%
Influenza Vaccination
22%
Fibroblast
22%
Neoplasm
22%
Oral Implants
21%
Obstructive Sleep Apnea
20%
Lung Cancer
19%
Cancer Cell
19%
Osseointegration
19%
Injury
19%
Growth Factor
18%
Chondrocyte
18%
Odds Ratio
17%
Hemodialysis
17%
Rehabilitation Engineering
17%
COVID-19
16%
Cell Therapy
16%
Thrombocyte Concentrate
16%
Endothelial Cell
16%
Surgery
16%
Blood Pressure
15%
Health Care Cost
15%
Infection
15%
Mesenchymal Stem Cell
15%
Breast Cancer
15%
Osteolysis
15%
Computer Assisted Tomography
15%
Programmed Cell Death
14%
Gelatin
14%
Knee
14%
Nanoparticle
14%
Epidermal Growth Factor Receptor
14%
Spinal Cord Injury
14%
Dental Implant
14%
Bone Regeneration
14%
Cell Proliferation
13%
Functional Electrical Stimulation
13%
Bone Graft
13%
Prevalence
13%
Drug Therapy
13%
Ossification
13%
Hydroxylapatite
13%
Platelet-Rich Fibrin
13%
Biological Marker
13%
Signal Transduction
13%
Gene Expression
12%
Metastatic Carcinoma
12%
Osteoarthritis
12%
Quality of Life
12%
Knee Osteoarthritis
12%
Osteoblast
12%
Adverse Event
12%
Cardiovascular Disease
12%
Electrostimulation
12%
Diabetes
12%
Clinical Trial
12%
Traumatic Brain Injury
12%
Urination
11%
Diagnosis
11%
Pulse Rate
11%
Asthma
11%
Acute Heart Infarction
11%
Cardiovascular System
11%
Upper Limb
11%
Parkinson's Disease
11%
Tumor Progression
11%
Combination Therapy
11%
Nephropathy
11%
Case-Control Study
10%
Calcium Sulfate
10%
Angiogenesis
10%
Particular Matter 2.5
10%
Atrial Fibrillation
10%
Magnetic Resonance Imaging
10%
Dental Pulp Stem Cell
10%
Bone Defect
10%
Heart Failure
10%
Tumor Necrosis Factor
10%
Vascular Endothelial Cell
10%
Cell Viability
10%
Edentulism
10%
Heart Rate Variability
10%